• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国 1990 年至 2019 年多发性骨髓瘤负担的变化趋势及其 2044 年预测

Secular Trends in the Burden of Multiple Myeloma From 1990 to 2019 and Its Projection Until 2044 in China.

机构信息

Clinical Research Service Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Guangdong Engineering Research Center of Collaborative Innovation Technology of Clinical Medical Big Data Cloud Service in Medical Consortium of West Guangdong Province, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

出版信息

Front Public Health. 2022 Jul 8;10:938770. doi: 10.3389/fpubh.2022.938770. eCollection 2022.

DOI:10.3389/fpubh.2022.938770
PMID:35875035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9304978/
Abstract

OBJECTIVE

Multiple myeloma (MM) imposes a heavy burden in China. Understanding the secular trend of MM burden and projecting its future trend could facilitate appropriate public health planning and improve the management of MM.

METHODS

Sex-specific incidence and mortality rates of MM in China from 1990 to 2019 were collected from the Global Burden of Disease 2019 study. The secular trend of MM burden was analyzed by joinpoint regression. Age-period-cohort model was used to analyze the effects of age, period, and birth cohort on MM burden and project future trends up to 2044.

RESULTS

From 1990 to 2019, the age-standardized incidence and mortality rates of MM continued to increase in males. For females, the age-standardized rates were stable in MM incidence and decreased in MM mortality. Males had a higher disease burden of MM than females. Age effects were the most significant risk factor for MM incidence and mortality. Moreover, the risk of MM incidence and mortality increased with increasing time period but decreased with birth cohort in males and females. The age-standardized incidence and mortality rates of MM in China is predicted to be continuously increasing over the next 25 years.

CONCLUSION

The burden of MM in China is expected to continue to increase in the future, with significant sex difference. A comprehensive understanding of the risk characteristics and disease pattern of MM could help develop timely intervention measures to effectively reduce its burden.

摘要

目的

多发性骨髓瘤(MM)在中国造成了沉重的负担。了解 MM 负担的长期趋势并预测其未来趋势,有助于进行适当的公共卫生规划并改善 MM 的管理。

方法

本研究收集了 1990 年至 2019 年全球疾病负担研究中中国 MM 的性别特异性发病率和死亡率数据。采用 Joinpoint 回归分析 MM 负担的长期趋势。采用年龄-时期-队列模型分析年龄、时期和出生队列对 MM 负担的影响,并预测至 2044 年的未来趋势。

结果

1990 年至 2019 年,男性 MM 的年龄标准化发病率和死亡率持续上升。对于女性,MM 的年龄标准化发病率保持稳定,而死亡率则下降。男性 MM 的疾病负担高于女性。年龄因素是 MM 发病率和死亡率的最重要危险因素。此外,男性和女性的 MM 发病率和死亡率均随时期增加而增加,但随出生队列增加而降低。中国 MM 的年龄标准化发病率和死亡率预计在未来 25 年内将持续上升。

结论

未来中国 MM 的负担预计将继续增加,且存在显著的性别差异。全面了解 MM 的风险特征和疾病模式有助于制定及时的干预措施,有效降低其负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/e661b62bbb59/fpubh-10-938770-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/f85fab5b0104/fpubh-10-938770-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/eba3977f95cd/fpubh-10-938770-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/e661b62bbb59/fpubh-10-938770-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/f85fab5b0104/fpubh-10-938770-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/eba3977f95cd/fpubh-10-938770-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e48f/9304978/e661b62bbb59/fpubh-10-938770-g0003.jpg

相似文献

1
Secular Trends in the Burden of Multiple Myeloma From 1990 to 2019 and Its Projection Until 2044 in China.中国 1990 年至 2019 年多发性骨髓瘤负担的变化趋势及其 2044 年预测
Front Public Health. 2022 Jul 8;10:938770. doi: 10.3389/fpubh.2022.938770. eCollection 2022.
2
Trend and projection of larynx cancer incidence and mortality in China from 1990 to 2044: A Bayesian age-period-cohort modeling study.1990 年至 2044 年中国喉癌发病率和死亡率的趋势和预测:基于贝叶斯年龄-时期-队列模型的研究。
Cancer Med. 2023 Aug;12(15):16517-16530. doi: 10.1002/cam4.6239. Epub 2023 Jun 12.
3
Comparison of secular trends of leukemia in China and the United States from 1990 to 2021 and their projections for the next 15 years.1990 年至 2021 年中国与美国白血病的时间趋势比较及其未来 15 年的预测。
Front Public Health. 2024 Aug 16;12:1425043. doi: 10.3389/fpubh.2024.1425043. eCollection 2024.
4
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years.1990 年至 2019 年中国白血病及其亚型疾病负担的变化趋势及其 25 年预测。
Ann Hematol. 2023 Sep;102(9):2375-2386. doi: 10.1007/s00277-023-05372-6. Epub 2023 Jul 19.
5
Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.1990年至2019年中国偏头痛发病率的长期趋势:连接点和年龄-时期-队列分析
J Pain Res. 2022 Jan 14;15:137-146. doi: 10.2147/JPR.S337216. eCollection 2022.
6
Secular trends in incidence and mortality of non-Hodgkin's lymphoma in China, 1990-2019, and predictions to 2030: Outlook for the future burden of disease.中国非霍奇金淋巴瘤发病率和死亡率的变化趋势,1990-2019 年,并预测至 2030 年:疾病负担的未来展望。
Tumori. 2024 Oct;110(5):348-354. doi: 10.1177/03008916241261166. Epub 2024 Aug 2.
7
Secular Trends in the Epidemiologic Patterns of Thyroid Cancer in China Over Three Decades: An Updated Systematic Analysis of Global Burden of Disease Study 2019 Data.三十年来中国甲状腺癌流行病学模式的变化趋势:基于全球疾病负担研究 2019 年数据的最新系统分析。
Front Endocrinol (Lausanne). 2021 Aug 30;12:707233. doi: 10.3389/fendo.2021.707233. eCollection 2021.
8
Incidence and mortality of multiple myeloma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016.2006-2016 年中国多发性骨髓瘤的发病率和死亡率:基于 2016 年全球疾病负担研究的分析。
J Hematol Oncol. 2019 Dec 10;12(1):136. doi: 10.1186/s13045-019-0807-5.
9
Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.中国 1990 年至 2017 年前列腺癌发病率和死亡率的趋势及年龄-时期-队列效应。
Public Health. 2019 Jul;172:70-80. doi: 10.1016/j.puhe.2019.04.016. Epub 2019 Jun 17.
10
Trends in the Incidence and Mortality of Diabetes in China from 1990 to 2017: A Joinpoint and Age-Period-Cohort Analysis.中国 1990 年至 2017 年糖尿病发病率和死亡率趋势:联合点和年龄-时期-队列分析。
Int J Environ Res Public Health. 2019 Jan 8;16(1):158. doi: 10.3390/ijerph16010158.

引用本文的文献

1
Time trends in multiple myeloma incidence and mortality across the BRICS from 1992 to 2021 and projection to 2046.1992年至2021年金砖国家多发性骨髓瘤发病率和死亡率的时间趋势及到2046年的预测。
BMC Public Health. 2025 May 13;25(1):1765. doi: 10.1186/s12889-025-22688-2.
2
Global, regional, and national multiple myeloma burden from 1990 to 2021: a systematic analysis for of the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家多发性骨髓瘤负担:全球疾病负担研究2021的系统分析
BMC Public Health. 2025 Mar 19;25(1):1054. doi: 10.1186/s12889-025-22240-2.
3
Comparison of secular trends of leukemia in China and the United States from 1990 to 2021 and their projections for the next 15 years.

本文引用的文献

1
Trends in the Incidence and DALYs of Urolithiasis From 1990 to 2019: Results From the Global Burden of Disease Study 2019.1990 年至 2019 年尿石症发病率和伤残调整生命年趋势:2019 年全球疾病负担研究结果。
Front Public Health. 2022 Mar 4;10:825541. doi: 10.3389/fpubh.2022.825541. eCollection 2022.
2
Diagnosis and Management of Multiple Myeloma: A Review.多发性骨髓瘤的诊断与治疗:综述
JAMA. 2022 Feb 1;327(5):464-477. doi: 10.1001/jama.2022.0003.
3
Secular Trends in the Incidence of Migraine in China from 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.
1990 年至 2021 年中国与美国白血病的时间趋势比较及其未来 15 年的预测。
Front Public Health. 2024 Aug 16;12:1425043. doi: 10.3389/fpubh.2024.1425043. eCollection 2024.
4
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years.1990 年至 2019 年中国白血病及其亚型疾病负担的变化趋势及其 25 年预测。
Ann Hematol. 2023 Sep;102(9):2375-2386. doi: 10.1007/s00277-023-05372-6. Epub 2023 Jul 19.
5
The quantification of circular RNA 0007841 during induction therapy helps estimate the response and survival benefits to bortezomib-based regimen in multiple myeloma.环状 RNA 0007841 在诱导治疗期间的定量分析有助于评估硼替佐米为基础的方案对多发性骨髓瘤的反应和生存获益。
Ir J Med Sci. 2024 Feb;193(1):17-25. doi: 10.1007/s11845-023-03410-w. Epub 2023 Jun 19.
6
Treatment benefit of upfront autologous stem cell transplantation for newly diagnosed multiple myeloma: a systematic review and meta-analysis.初诊多发性骨髓瘤患者行自体造血干细胞移植治疗的获益:系统评价和荟萃分析。
BMC Cancer. 2023 May 16;23(1):446. doi: 10.1186/s12885-023-10907-1.
7
Global, regional, and national years lived with disability due to blindness and vision loss from 1990 to 2019: Findings from the Global Burden of Disease Study 2019.全球、地区和国家因失明和视力丧失导致的残疾年数:2019 年全球疾病负担研究结果。
Front Public Health. 2022 Oct 28;10:1033495. doi: 10.3389/fpubh.2022.1033495. eCollection 2022.
1990年至2019年中国偏头痛发病率的长期趋势:连接点和年龄-时期-队列分析
J Pain Res. 2022 Jan 14;15:137-146. doi: 10.2147/JPR.S337216. eCollection 2022.
4
Secular Trend in the Incidence of Conduct Disorder in China from 1990 to 2019: A Joinpoint and Age-Period-Cohort Analysis.1990 年至 2019 年中国品行障碍发病率的长期趋势:联合分析和年龄-时期-队列分析。
J Dev Behav Pediatr. 2022;43(5):e339-e346. doi: 10.1097/DBP.0000000000001049. Epub 2022 Jan 10.
5
Economic Burden of Major Diseases in China in 2013.2013 年中国重大疾病经济负担
Front Public Health. 2021 May 19;9:649624. doi: 10.3389/fpubh.2021.649624. eCollection 2021.
6
Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019.测量 1990 年至 2019 年全球、区域和国家多发性骨髓瘤的负担。
BMC Cancer. 2021 May 25;21(1):606. doi: 10.1186/s12885-021-08280-y.
7
[Influence of prognostic nutritional index and controlling nutritional status on the prognosis of patients with multiple myeloma].[预后营养指数及控制营养状况对多发性骨髓瘤患者预后的影响]
Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):332-337. doi: 10.3760/cma.j.issn.0253-2727.2021.04.011.
8
Global, regional and national disability-adjusted life years due to HIV from 1990 to 2019: findings from the Global Burden of Disease Study 2019.全球、区域和国家因艾滋病毒导致的残疾调整生命年(DALYs):来自 2019 年全球疾病负担研究的发现。
Trop Med Int Health. 2021 Jun;26(6):610-620. doi: 10.1111/tmi.13565. Epub 2021 Mar 18.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
Trends of incidence, mortality and survival of multiple myeloma in Spain. A twenty-three-year population-based study.西班牙多发性骨髓瘤发病率、死亡率和生存率趋势。一项基于人群的 23 年研究。
Clin Transl Oncol. 2021 Jul;23(7):1429-1439. doi: 10.1007/s12094-020-02541-1. Epub 2021 Jan 12.